Hydroxychloroquine sulfate Indications And Usage

Revision as of 23:57, 7 January 2014 by Chetan Lokhande (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Hydroxychloroquine sulfate
HYDROXYCHLOROQUINE SULFATE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications And Usage
Contraindications
Warnings And Precautions
Adverse Reactions
Overdosage
Dosage And Administration
How Supplied
Labels And Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Indications And Usage

Hydroxychloroquine sulfate tablets, USP are indicated for the suppressive treatment and treatment of acute attacks of malaria due to Plasmodium vivax, P. malariae, P. ovale, and susceptible strains of P. falciparum. Hydroxychloroquine sulfate tablets, USP are also indicated for the treatment of discoid and systemic lupus erythematosus, and rheumatoid arthritis.[1]

References

  1. "HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE) TABLET, FILM COATED [IPCA LABORATORIES LIMITED]".

Adapted from the FDA Package Insert.